Literature DB >> 893417

Human blood coagulation factor XI. Purification, properties, and mechanism of activation by activated factor XII.

B N Bouma, J H Griffin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 893417

Source DB:  PubMed          Journal:  J Biol Chem        ISSN： 0021-9258            Impact factor:   5.157


× No keyword cloud information.
  52 in total

1.  Coagulation procofactor activation by factor XIa.

Authors:  M F Whelihan; T Orfeo; M T Gissel; K G Mann
Journal:  J Thromb Haemost       Date:  2010-05-04       Impact factor: 5.824

2.  Evidence against a protein in plasma that is a product of a factor XI mRNA splice variant missing exons 6 and 7.

Authors:  David Gailani; Mao-Fu Sun; Qiufang Cheng; Anton Matafonov; Erik I Tucker; Andras Gruber; Jonas Emsley
Journal:  Blood       Date:  2010-08-19       Impact factor: 22.113

3.  Mechanisms and specificity of factor XIa and trypsin inhibition by protease nexin 2 and basic pancreatic trypsin inhibitor.

Authors:  Duraiswamy Navaneetham; Dipali Sinha; Peter N Walsh
Journal:  J Biochem       Date:  2010-07-20       Impact factor: 3.387

4.  Absence of in vitro Procoagulant Activity in Immunoglobulin Preparations due to Activated Coagulation Factors.

Authors:  Adriana E Oviedo; María E Bernardi; Hugo A Guglielmone; María S Vitali
Journal:  Transfus Med Hemother       Date:  2015-10-06       Impact factor: 3.747

5.  Exosite-mediated substrate recognition of factor IX by factor XIa. The factor XIa heavy chain is required for initial recognition of factor IX.

Authors:  Taketoshi Ogawa; Ingrid M Verhamme; Mao-Fu Sun; Paul E Bock; David Gailani
Journal:  J Biol Chem       Date:  2005-04-13       Impact factor: 5.157

6.  Allosteric inhibition of factor XIa. Sulfated non-saccharide glycosaminoglycan mimetics as promising anticoagulants.

Authors:  Rami A Al-Horani; David Gailani; Umesh R Desai
Journal:  Thromb Res       Date:  2015-04-22       Impact factor: 3.944

Review 7.  Bradykinin formation. Plasma and tissue pathways and cellular interactions.

Authors:  A P Kaplan; K Joseph; Y Shibayama; Y Nakazawa; B Ghebrehiwet; S Reddigari; M Silverberg
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

Review 8.  Recent advances in the discovery and development of factor XI/XIa inhibitors.

Authors:  Rami A Al-Horani; Daniel K Afosah
Journal:  Med Res Rev       Date:  2018-05-04       Impact factor: 12.944

9.  An insertion mutation of the bovine Fii gene is responsible for factor XI deficiency in Japanese black cattle.

Authors:  Masaki Kunieda; Takehito Tsuji; Abdol Rahim Abbasi; Maryam Khalaj; Miho Ikeda; Keiko Miyadera; Hiroyuki Ogawa; Tetsuo Kunieda
Journal:  Mamm Genome       Date:  2005-05       Impact factor: 2.957

10.  Ir-CPI, a coagulation contact phase inhibitor from the tick Ixodes ricinus, inhibits thrombus formation without impairing hemostasis.

Authors:  Yves Decrem; Géraldine Rath; Virginie Blasioli; Philippe Cauchie; Séverine Robert; Jérôme Beaufays; Jean-Marie Frère; Olivier Feron; Jean-Michel Dogné; Chantal Dessy; Luc Vanhamme; Edmond Godfroid
Journal:  J Exp Med       Date:  2009-10-05       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.